EMA Authorised: Trimbow (beclometasone dipropionate;formoterol fumarate dihydrate;glycopyrronium bromide) — Chiesi Farmaceutici S.p.A.

View source ↗

Summary

The European Medicines Agency has authorised Trimbow, a fixed-dose inhaler containing beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trimbow (budesonide/formoterol/glycopyrronium)

Snippet

Status: Authorised. Therapeutic area: Pulmonary Disease, Chronic Obstructive. MAH: Chiesi Farmaceutici S.p.A.. Decision date: 16/03/2026